Dimerix Ltd

(SBMJF)

By |

Profile

Dimerix Ltd is a clinical stage biotechnology company. The company is focused on developing new therapeutics discovered using its proprietary drug development platform, Receptor-Heteromer Identification Technology (HIT). The company focus is on the development of its DMX-200 clinical asset for the treatment of Chronic Kidney Disease (CKD). The Chronic Kidney Disease also has subgroups namely Focal Segmental Glomerulosclerosis (FSGS) and Diabetic Kidney Disease (DKD).

Contact Information

Website: www.dimerix.com
Main Phone: +61 893888290
Address: 63 Exhibition Street
Address 2: Level 11, P.O. Box 24231
State: VIC
City / Town: Melbourne
Country: AUS
Postal Code: 3000

Issuer Information

Exchange: GREY
$ 0.0001 $ 0. (0.00%)
Last Price 0.0001 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.0001
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap 15,880 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 158,799,437.00 EPS (TTM) -0.02 PE Ratio N/A Exchange Greys